Kathmere Capital Management LLC Increases Position in CME Group Inc. $CME

Kathmere Capital Management LLC lifted its position in CME Group Inc. (NASDAQ:CMEFree Report) by 79.0% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 5,283 shares of the financial services provider’s stock after acquiring an additional 2,331 shares during the period. Kathmere Capital Management LLC’s holdings in CME Group were worth $1,560,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Abel Hall LLC purchased a new position in shares of CME Group in the first quarter worth about $334,000. Whittier Trust Co. of Nevada Inc. boosted its position in CME Group by 33.8% in the first quarter. Whittier Trust Co. of Nevada Inc. now owns 7,183 shares of the financial services provider’s stock valued at $2,216,000 after buying an additional 1,815 shares during the last quarter. Bogart Wealth LLC increased its holdings in CME Group by 2.5% in the 1st quarter. Bogart Wealth LLC now owns 58,807 shares of the financial services provider’s stock worth $17,369,000 after buying an additional 1,435 shares during the period. Ascentis Independent Advisors increased its holdings in CME Group by 13.0% in the 1st quarter. Ascentis Independent Advisors now owns 4,624 shares of the financial services provider’s stock worth $1,366,000 after buying an additional 532 shares during the period. Finally, Stephens Inc. AR raised its position in CME Group by 7.1% during the 1st quarter. Stephens Inc. AR now owns 3,911 shares of the financial services provider’s stock worth $1,155,000 after buying an additional 258 shares during the last quarter. Hedge funds and other institutional investors own 87.75% of the company’s stock.

Analyst Upgrades and Downgrades

CME has been the topic of several recent research reports. Raymond James Financial reaffirmed an “outperform” rating and issued a $320.00 price objective on shares of CME Group in a report on Thursday. Morgan Stanley reduced their target price on shares of CME Group from $362.00 to $353.00 and set an “overweight” rating for the company in a report on Thursday, April 23rd. Wall Street Zen upgraded shares of CME Group from a “sell” rating to a “hold” rating in a research report on Saturday, June 13th. UBS Group reaffirmed an “overweight” rating on shares of CME Group in a report on Monday, June 15th. Finally, The Goldman Sachs Group cut their price target on CME Group from $267.00 to $245.00 and set a “sell” rating on the stock in a research report on Tuesday, June 30th. Twelve research analysts have rated the stock with a Buy rating, four have issued a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, CME Group has a consensus rating of “Moderate Buy” and an average price target of $300.94.

View Our Latest Research Report on CME

CME Group Price Performance

Shares of NASDAQ CME opened at $236.60 on Monday. The stock has a market capitalization of $85.73 billion, a price-to-earnings ratio of 20.19, a PEG ratio of 2.65 and a beta of 0.25. CME Group Inc. has a 12 month low of $218.31 and a 12 month high of $329.16. The firm’s 50 day simple moving average is $267.17 and its 200-day simple moving average is $284.36. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02.

CME Group (NASDAQ:CMEGet Free Report) last posted its earnings results on Wednesday, April 22nd. The financial services provider reported $3.36 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.11 by $0.25. CME Group had a net margin of 63.19% and a return on equity of 15.42%. The firm had revenue of $1.88 billion during the quarter, compared to analysts’ expectations of $1.77 billion. During the same period in the previous year, the business posted $2.80 EPS. The business’s revenue was up 14.5% compared to the same quarter last year. Analysts expect that CME Group Inc. will post 12.28 EPS for the current year.

CME Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, June 25th. Shareholders of record on Tuesday, June 9th were given a $1.30 dividend. The ex-dividend date was Tuesday, June 9th. This represents a $5.20 dividend on an annualized basis and a dividend yield of 2.2%. CME Group’s dividend payout ratio is 44.37%.

Insider Transactions at CME Group

In related news, insider Hilda Harris Piell sold 5,753 shares of the company’s stock in a transaction dated Monday, May 18th. The stock was sold at an average price of $304.63, for a total value of $1,752,536.39. Following the completion of the transaction, the insider owned 27,702 shares of the company’s stock, valued at approximately $8,438,860.26. This represents a 17.20% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Terrence A. Duffy sold 35,000 shares of the business’s stock in a transaction that occurred on Friday, May 15th. The shares were sold at an average price of $298.51, for a total value of $10,447,850.00. Following the completion of the sale, the chief executive officer owned 55,630 shares of the company’s stock, valued at $16,606,111.30. This trade represents a 38.62% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Corporate insiders own 0.30% of the company’s stock.

CME Group Profile

(Free Report)

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.

Read More

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.